Melissa Fleur Afshar is a Newsweek reporter based in London, United Kingdom. Her current focus is on trending life stories and human-interest features on a variety of topics ranging from ...
In May 2023, a novel tracer, flotufolastat F 18 (POSLUMA®), formerly referred to as 18 F-rhPSMA-7.3, was approved by the FDA as a PSMA-PET tracer for the staging of prostate cancer patients with a ...
We read every piece of feedback, and take your input very seriously.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback